Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis
Haidong Dong, … , Colin L.W. Driscoll, Lieping Chen
Haidong Dong, … , Colin L.W. Driscoll, Lieping Chen
Published February 1, 2003
Citation Information: J Clin Invest. 2003;111(3):363-370. https://doi.org/10.1172/JCI16015.
View: Text | PDF
Article Immunology

Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis

  • Text
  • PDF
Abstract

A pathogenic hallmark of rheumatoid arthritis (RA) is persistent activation of self-reactive CD4+ T cells. The cause of this aberrant activity remains elusive. We report here detection of autoantibodies against B7-H1, a recently described member of the B7 family, in 29% of patients with RA versus 4% of healthy donors. High-level expression of cell surface B7-H1 are found on activated human CD4+, CD8+, and CD45RO+ T cells. Immobilized autoantibodies to B7-H1 are capable of costimulating the proliferation of CD4+ T cells in vitro, and the presence of these autoantibodies correlates with active disease status. Using immobilized B7-H1 mAb’s and programmed death 1Ig, we demonstrate that engagement of B7-H1 on CD4+ T cells costimulates proliferation and secretion of IL-10, and subsequently leads to programmed cell death, accompanied with upregulated expression of TNF-related apoptosis–inducing ligand and activation of caspase-3. Taken together with our previous findings, these data indicate a bidirectional signaling role of B7-H1 in T cell costimulation and apoptosis and implicate B7-H1 autoantibodies as contributing to the progression of RA by inducing aberrant T cell responses.

Authors

Haidong Dong, Scott E. Strome, Eric L. Matteson, Kevin G. Moder, Dallas B. Flies, Gefeng Zhu, Hideto Tamura, Colin L.W. Driscoll, Lieping Chen

×

Total citations by year

Year: 2024 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2004 2003 Total
Citations: 2 7 10 6 4 3 4 8 4 2 6 3 1 2 2 5 1 3 3 4 80
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (80)

Title and authors Publication Year
Exploring the Complexity and Promise of Tumor Immunotherapy in Drug Development
Feng Y, He C, Liu C, Shao B, Wang D, Wu P
International journal of molecular sciences 2024
Exploring the gut microbiome: probiotics, prebiotics, synbiotics, and postbiotics as key players in human health and disease improvement
Kim YT, Mills DA
Food Science and Biotechnology 2024
Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
Long Y, Yu X, Chen R, Tong Y, Gong L
Frontiers in immunology 2022
CMTM6 as a master regulator of PD-L1.
Yaseen MM, Abuharfeil NM, Darmani H
Cancer Immunology, Immunotherapy 2022
Bridging the Gap: Connecting the Mechanisms of Immune-Related Adverse Events and Autoimmunity Through PD-1
Mor A, Strazza M
Frontiers in Cell and Developmental Biology 2022
Beyond Cancer: Regulation and Function of PD-L1 in Health and Immune-Related Diseases
Beenen AC, Sauerer T, Schaft N, Dörrie J
International journal of molecular sciences 2022
Plasma autoantibodies IgG and IgM to PD1/PDL1 as potential biomarkers and risk factors of lung cancer.
Li J, Liu M, Zhang X, Ji L, Yang T, Zhao Y, Wang Z, Liang F, Dai L
Journal of Cancer Research and Clinical Oncology 2022
Tumor microenvironment antigens.
Andersen MH
Seminars in Immunopathology 2022
Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Pyo JY, Yoon T, Ahn SS, Song JJ, Park YB, Lee SW
Scientific Reports 2022
PD-1/PD-L1 Axis as a Potential Therapeutic Target for Multiple Sclerosis: A T Cell Perspective
HX Li, C Zheng, J Han, J Zhu, S Liu, T Jin
Frontiers in cellular neuroscience 2021
The Role of Programmed Death-1 in Type 1 Diabetes
CG Tucker, AJ Dwyer, BT Fife, T Martinov
Current Diabetes Reports 2021
The PD-1:PD-L1 axis in Inflammatory Arthritis
M Canavan, A Floudas, DJ Veale, U Fearon
BMC Rheumatology 2021
The generation of PD-L1 and PD-L2 in cancer cells: From nuclear chromatin reorganization to extracellular presentation
Z Fan, C Wu, M Chen, Y Jiang, Y Wu, R Mao, Y Fan
Acta pharmaceutica Sinica. B 2021
Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis
J Zhao, P Jiang, S Guo, S Schrodi, D He
Frontiers in immunology 2021
Single-cell transcriptome analysis of the heterogeneous effects of differential expression of tumor PD-L1 on responding TCR-T cells.
Ding R, Liu S, Wang S, Chen H, Wang F, Xu Q, Zhu L, Dong X, Gu Y, Zhang X, Chao CC, Gao Q
Theranostics 2021
Adipose-Tissue-Derived Mesenchymal Stem Cells Mediate PD-L1 Overexpression in the White Adipose Tissue of Obese Individuals, Resulting in T Cell Dysfunction.
Eljaafari A, Pestel J, Le Magueresse-Battistoni B, Chanon S, Watson J, Robert M, Disse E, Vidal H
Cells 2021
Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy.
Khalique H, Baugh R, Dyer A, Scott EM, Frost S, Larkin S, Lei-Rossmann J, Seymour LW
Journal for ImmunoTherapy of Cancer 2021
Low Infiltration of CD8+ PD-L1+ T Cells and M2 Macrophages Predicts Improved Clinical Outcomes After Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Carcinoma.
Li L, Lu G, Liu Y, Gong L, Zheng X, Zheng H, Gu W, Yang L
Frontiers in Oncology 2021
Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy.
Tan Q, Dai L, Wang Y, Liu S, Liang T, Luo R, Wang S, Lou N, Chen H, Zhou Y, Zhong Q, Yang J, Xing P, Hu X, Liu Y, Zhou S, Yao J, Wu D, Zhang Z, Tang L, Yu X, Han X, Shi Y
Cancer Immunology, Immunotherapy 2021
Differential effects of PD-L1 versus PD-1 blockade on myeloid inflammation in human lung cancer and myeloma
Noffar Bar, Federica Costa, Rituparna Das, Alyssa Duffy, Mehmet K. Samur, Samuel S. McCachren, Scott Gettinger, Natalia Neparidze, Terri L. Parker, Jithendra Kini Bailur, Katherine E. Pendleton, Richa Bajpai, Lin Zhang, Mina L. Xu, Tara Anderson, Nicola Giuliani, Ajay K. Nooka, Hearn J. Cho, Aparna Raval, Mala Shanmugam, Kavita M. Dhodapkar, Madhav Dhodapkar
JCI Insight 2020
Autoantibody profiling identifies predictive biomarkers of response to anti-PD1 therapy in cancer patients
Q Tan, D Wang, J Yang, P Xing, S Yang, Y Li, Y Qin, X He, Y Liu, S Zhou, H Duan, T Liang, H Wang, Y Wang, S Jiang, F Zhao, Q Zhong, Y Zhou, S Wang, J Dai, J Yao, D Wu, Z Zhang, Y Sun, X Han, X Yu, Y Shi
Theranostics 2020
Quantifying PD-L1 Expression to Monitor Immune Checkpoint Therapy: Opportunities and Challenges
S Nimmagadda
Cancers 2020
Combination rhIL-15 and Anti-PD-L1 (Avelumab) Enhances HIVGag-Specific CD8 T-Cell Function
BA Goshu, H Chen, M Moussa, J Cheng, M Catalfamo
The Journal of Infectious Diseases 2020
PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer
B Diskin, S Adam, MF Cassini, G Sanchez, M Liria, B Aykut, C Buttar, E Li, B Sundberg, RD Salas, R Chen, J Wang, M Kim, MS Farooq, S Nguy, C Fedele, KH Tang, T Chen, W Wang, M Hundeyin, JA Rossi, E Kurz, MI Haq, J Karlen, E Kruger, Z Sekendiz, D Wu, SA Shadaloey, G Baptiste, G Werba, S Selvaraj, C Loomis, KK Wong, J Leinwand, G Miller
Nature Immunology 2020
Lung Cancer Survival in Patients With Autoimmune Disease.
Jacob S, Rahbari K, Tegtmeyer K, Zhao J, Tran S, Helenowski I, Zhang H, Walunas T, Varga J, Dematte J, Villaflor V
2020
The evolving role of immuno-oncology for the treatment of head and neck cancer: I-O and Head and Neck Cancer
AL Strome, X Zhang, SE Strome
Laryngoscope Investigative Otolaryngology 2019
Hepatic expression of programmed death-1 (PD-1) and its ligand, PD-L1, in children with autoimmune hepatitis: relation to treatment response
H Agina, N Ehsan, T Abd-Elaziz, G Abd-Elfatah, E Said, M Sira
Clinical and Experimental Hepatology 2019
Inflammation induced PD-L1-specific T cells
S Munir, MT Lundsager, MA Jørgensen, M Hansen, TH Petersen, CM Bonefeld, C Friese, Ö Met, P thor Straten, MH Andersen
2019
A Novel Anti-PD-L1 Vaccine for Cancer Immunotherapy and Immunoprevention
J Chen, H Liu, T Jehng, Y Li, Z Chen, KD Lee, HT Shen, L Jones, XF Huang, SY Chen
Cancers 2019
The T-win® technology: immune-modulating vaccines
MH Andersen
Seminars in Immunopathology 2018
Immune Checkpoints as Therapeutic Targets in Autoimmunity
C Paluch, AM Santos, C Anzilotti, RJ Cornall, SJ Davis
Frontiers in immunology 2018
Inhibitory Receptors and Pathways of Lymphocytes: The Role of PD-1 in Treg Development and Their Involvement in Autoimmunity Onset and Cancer Progression
E Gianchecchi, A Fierabracci
Frontiers in immunology 2018
Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients
H Shi, J Ye, J Teng, Y Yin, Q Hu, X Wu, H Liu, X Cheng, Y Su, M Liu, J Gu, T Lu, HJ Chen, H Zheng, Y Sun, C Yang
Arthritis Research & Therapy 2017
Functional Expression of Programmed Death-Ligand 1 (B7-H1) by Immune Cells and Tumor Cells
RM Johnson, H Dong
Frontiers in immunology 2017
Cancer Clonal Theory, Immune Escape, and Their Evolving Roles in Cancer Multi-Agent Therapeutics
JL Messerschmidt, P Bhattacharya, GL Messerschmidt
Current Oncology Reports 2017
PD-1 expression and clinical PD-1 blockade in B-cell lymphomas
ZY Xu-Monette, J Zhou, KH Young
Blood 2017
Anti-regulatory T cells
MH Andersen
Seminars in Immunopathology 2016
A Cytokine-Independent Approach To Identify Antigen-Specific Human Germinal Center T Follicular Helper Cells and Rare Antigen-Specific CD4+ T Cells in Blood
JM Dan, CS Arlehamn, D Weiskopf, RS Antunes, C Havenar-Daughton, SM Reiss, M Brigger, M Bothwell, A Sette, S Crotty
Journal of immunology (Baltimore, Md. : 1950) 2016
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
W Zou, JD Wolchok, L Chen
Science Translational Medicine 2016
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity
Q Zhang, DA Vignali
Immunity 2016
Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis induction
D Hendriks, Y He, I Koopmans, VR Wiersma, RJ van Ginkel, DF Samplonius, W Helfrich, E Bremer
OncoImmunology 2016
Soluble programmed cell death receptor-1 (sPD-1): a potential biomarker with anti-inflammatory properties in human and experimental acute respiratory distress syndrome (ARDS)
SF Monaghan, CS Chung, Y Chen, J Lomas-Neira, WG Fairbrother, DS Heffernan, WG Cioffi, A Ayala
Journal of Translational Medicine 2016
Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti–programed death-ligand 1 (Avelumab)
AL Gill, SA Green, S Abdullah, CL Saout, S Pittaluga, H Chen, R Turnier, J Lifson, S Godin, J Qin, MC Sneller, JM Cuillerot, H Sabzevari, HC Lane, M Catalfamo
AIDS 2016
B7-H1 antibodies lose antitumor activity due to activation of p38 MAPK that leads to apoptosis of tumor-reactive CD8+ T cells
X Liu, X Wu, S Cao, SM Harrington, P Yin, AS Mansfield, H Dong
Scientific Reports 2016
Hepatic stellate cells: central modulators of hepatic carcinogenesis
AI Thompson, KP Conroy, NC Henderson
BMC Gastroenterology 2015
Immune Regulation by Self-Recognition: Novel Possibilities for Anticancer Immunotherapy
MH Andersen
JNCI Journal of the National Cancer Institute 2015
Comparison of biomarkers for systemic juvenile idiopathic arthritis
S Shenoi, JN Ou, C Ni, C Macaubas, VH Gersuk, CA Wallace, ED Mellins, AM Stevens
Pediatric Research 2015
Signaling pathway and dysregulation of PD1 and its ligands in lymphoid malignancies
Y Xia, LJ Medeiros, KH Young
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2015
Influence of PD-L1 cross-linking on cell death in PD-L1-expressing cell lines and bovine lymphocytes
R Ikebuchi, S Konnai, T Okagawa, K Yokoyama, C Nakajima, Y Suzuki, S Murata, K Ohashi
Immunology 2014
Targeting Apoptosis in Autoimmune Hepatitis
AJ Czaja
Digestive Diseases and Sciences 2014
Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality
A Saha, K Aoyama, PA Taylor, BH Koehn, RG Veenstra, A Panoskaltsis-Mortari, DH Munn, WJ Murphy, M Azuma, H Yagita, BT Fife, MH Sayegh, N Najafian, G Socie, R Ahmed, GJ Freeman, AH Sharpe, BR Blazar
Blood 2013
Immune evasion of mantle cell lymphoma: expression of B7-H1 leads to inhibited T-cell response to and killing of tumor cells
L Wang, J Qian, Y Lu, H Li, H Bao, D He, Z Liu, Y Zheng, J He, Y Li, S Neelapu, J Yang, LW Kwak, Q Yi, Z Cai
Haematologica 2013
Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer
M Sznol, L Chen
Clinical cancer research 2013
PD-L1 is increased in the spinal cord and infiltrating lymphocytes in experimental allergic encephalomyelitis
M Li, J Jiang, B Fu, J Chen, Q Xue, W Dong, Y Gu, L Tang, L Xue, Q Fang, M Wang, X Zhang
NEURAL REGEN RES 2013
The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4 + T cells
S Munir, GH Andersen, IM Svane, MH Andersen
OncoImmunology 2013
Structure and Interactions of the Human Programmed Cell Death 1 Receptor
X Cheng, V Veverka, A Radhakrishnan, LC Waters, FW Muskett, SH Morgan, J Huo, C Yu, EJ Evans, AJ Leslie, M Griffiths, C Stubberfield, R Griffin, AJ Henry, A Jansson, JE Ladbury, S Ikemizu, MD Carr, SJ Davis
The Journal of biological chemistry 2013
Immunoregulatory molecules are master regulators of inflammation during the immune response
H la Fuente, D Cibrián, F Sánchez-Madrid
FEBS Letters 2012
B7-H1 expression is associated with expansion of regulatory T cells in colorectal carcinoma
D Hua, J Sun, Y Mao, LJ Chen, YY Wu, XG Zhang
World journal of gastroenterology : WJG 2012
Tubular cell HIV-entry through apoptosed CD4 T cells: A novel pathway
P Singh, H Goel, M Husain, X Lan, J Mikulak, A Malthotra, S Teichberg, H Schmidtmayerova, PC Singhal
Virology 2012
B7-h1 expressed by activated CD8 T cells is essential for their survival
V Pulko, KJ Harris, X Liu, RM Gibbons, SM Harrington, CJ Krco, ED Kwon, H Dong
Journal of immunology (Baltimore, Md. : 1950) 2011
B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance
JJ Park, R Omiya, Y Matsumura, Y Sakoda, A Kuramasu, MM Augustine, S Yao, F Tsushima, H Narazaki, S Anand, Y Liu, SE Strome, L Chen, K Tamada
Blood 2010
B7-H1 expression on old CD8+ T cells negatively regulates the activation of immune responses in aged animals
N Mirza, MA Duque, AL Dominguez, AG Schrum, H Dong, J Lustgarten
Journal of immunology (Baltimore, Md. : 1950) 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Potential Role of Decoy B7-H4 in the Pathogenesis of Rheumatoid Arthritis: A Mouse Model Informed by Clinical Data
T Azuma, G Zhu, H Xu, AC Rietz, CG Drake, EL Matteson, L Chen, YJ Liu
PLoS Medicine 2009
The complex role of B7 molecules in tumor immunology
B Seliger, FM Marincola, S Ferrone, H Abken
Trends in Molecular Medicine 2008
Blockade of endogenous B7-H1 suppresses antibacterial protection after primary Listeria monocytogenes infection
SK Seo, HY Jeong, SG Park, SW Lee, IW Choi, L Chen, I Choi
Immunology 2008
TREM-2 mediated signaling induces antigen uptake and retention in mature myeloid dendritic cells.
Radhakrishnan S, Arneson LN, Upshaw JL, Howe CL, Felts SJ, Colonna M, Leibson PJ, Rodriguez M, Pease LR
Journal of immunology (Baltimore, Md. : 1950) 2008
PDL-1 blockade impedes T cell expansion and protective immunity primed by attenuated Listeria monocytogenes.
Rowe JH, Johanns TM, Ertelt JM, Way SS
Journal of immunology (Baltimore, Md. : 1950) 2008
PD-1 and Its Ligands in Tolerance and Immunity
Keir ME, Butte MJ, Freeman GJ, Sharpe AH
Annual Review of Immunology 2008
Polymorphisms of Genes for Programmed Cell Death 1 Ligands in Patients with Rheumatoid Arthritis
SC Wang, CH Lin, RN Li, TT Ou, CC Wu, WC Tsai, HW Liu, JH Yen
Journal of Clinical Immunology 2007
Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma
ZZ Yang, AJ Novak, MJ Stenson, TE Witzig, SM Ansell
Blood 2006
Advances in Immunology
AJ Korman, KS Peggs, JP Allison
Advances in immunology 2006
The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.
Ghebeh H, Mohammed S, Al-Omair A, Qattan A, Lehe C, Al-Qudaihi G, Elkum N, Alshabanah M, Bin Amer S, Tulbah A, Ajarim D, Al-Tweigeri T, Dermime S
Neoplasia (New York, N.Y.) 2006
Costimulation-based immunotherapy for head and neck cancer
SE Strome, L Chen
Current Treatment Options in Oncology 2004
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
RH Thompson, MD Gillett, JC Cheville, CM Lohse, H Dong, WS Webster, KG Krejci, JR Lobo, S Sengupta, L Chen, H Zincke, ML Blute, SE Strome, BC Leibovich, ED Kwon
Proceedings of the National Academy of Sciences 2004
PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells
YE Latchman, SC Liang, Y Wu, T Chernova, RA Sobel, M Klemm, VK Kuchroo, GJ Freeman, AH Sharpe
Proceedings of the National Academy of Sciences 2004
Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation
Rachel M. McLoughlin, Janusz Witowski, Rachel L. Robson, Thomas S. Wilkinson, Suzanne M. Hurst, Anwen S. Williams, John D. Williams, Stefan Rose-John, Simon A. Jones, Nicholas Topley
Journal of Clinical Investigation 2003
Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis
AD Salama, T Chitnis, J Imitola, MJ Ansari, H Akiba, F Tushima, M Azuma, H Yagita, MH Sayegh, SJ Khoury
Journal of Experimental Medicine 2003
Immunology of B7-H1 and Its Roles in Human Diseases
H Tamura, K Ogata, H Dong, L Chen
International Journal of Hematology 2003
B7-H1 pathway and its role in the evasion of tumor immunity
H Dong, L Chen
Journal of Molecular Medicine 2003

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts